Difference between revisions of "Part:BBa K3064014"

Line 1: Line 1:
  
 
__NOTOC__
 
__NOTOC__
<partinfo>BBa_K3064000 short</partinfo>
+
<partinfo>BBa_K3064014 short</partinfo>
  
It is a binding site of CHREBP.
+
This is a functional unit of the HepG2, which expresses fusioned hsaGlucagon-GGGGS-hsaIgG-Fc and HA-hsaTrim21 by automatic cleavage of P2A.
  
 
<!-- Add more about the biology of this part here -->
 
<!-- Add more about the biology of this part here -->
 
===Usage and Biology===
 
===Usage and Biology===
  
Some glycolytic and lipogenic genes respond primarily to glucose, not to insulin. This led to the identification of a consensus sequence that is required for glucose-responsiveness, termed the carbohydrate response element (ChoRE), comprising of two E-boxes (CACGTG) or E-box-like sequences separated by 5 bp [3-5].
+
Our composite part BBa_K3064014 play a necessary effect in our whole RECEPTOR KILLER system. This part is designed to recognised and bind with target protein,and then recruit the proteasome to deplete the target protein through the ubiquitin-proteasome pathway.
 +
In this part, hsaGlucagon acts as a bait,which can bind with GCGR, and is linked together with hsalgG-Fc by the designed 4xGS linker to form a recombinate GFP antibody.
 +
Trim21, the E3 ubiquitin ligase, plays the most important role in the degradation system. The C-terminal B30.2 domain on trim21 offers a site for the conservative Fc region of human lgG 1,2 and 4 to bind with[1]. When Glucagon is linked to the hsalgG1-Fc, and after the antibody-antigen interaction, a ternary complex is build up. The trim21 then functions as a E3 ubiquitin ligase and proceeds the complex to be depleted through the ubiquitin-proteasome pathway.
  
Carbohydrate response element binding protein (ChREBP) is an important transcription that can regulate the expression of key genes involved in various pathways including glycolysis, gluconeogenesis and lipogenesis. It does this by forming a tetrameric complex made up of two ChREBP/Mlx heterodimers, which enables it to bind to the carbohydrate response element (ChoRE) in the promoter region. ChoRE should be widely applicable to studying the influence of glucose consentration to cells .
 
  
https://static.igem.org/mediawiki/parts/4/4c/T--NUDT_CHINA--part-CHoRE_1.jpg
 
 
Figure 1: ChREBP bind with ChoRE
 
 
 
The basic part BBa_K3064000 is an important part in our next experiment. The different number of CHoRE are set in other parts. And the part BBa_K3064026 shows his function. This part BBa_K3064026 was cloned in pGL3 and transfected into HepG2 cell lines using Invitrogen LipofectamineTM 3000. Protocol could be found in our Experiment page.
 
<p><ahref="https://2019.igem.org/wiki/images/1/1b/T--NUDT_CHINA--Protocol_for_lipo3000_transfection_with_Lipofectamine%E2%84%A2_3000_Reagent.pdf">Click to see </ a></p >
 
To conduct the later function test, we set five different groups to conduct the transfection. They are pGL3-9xGSP(glucogon sensor promoter)-GFP , pGL3-6xGSP-GFP, pGL3-3xGSP-GFP, pGL3-minip-GFPand plv-mcherry as the internal control. We transfected 300μg into HepG2 cells, which were cultured on 24-hole plate. When 90 percent  were mixed, we begin the transfection.
 
At the very first beginning, we starved the HepG2 cells with DMEM for 2 hours before transfection begins.After transfection 12h, we starved the cells with glucose-free culture and stimulate with 20mM glucose concentration culture after 6 more hours. Glucose stimulation intensity was controlled at 20mM. Samples were tested after transfection of 48h.
 
  
 +
===Special Design===
 +
As a key functional element, special designs are taken for to optimize the applicability and adaptive of such parts . Our part is mainly composed of two important genes, and the efficient expression of these two genes and how to connect them become the focus of our design.
 +
Firstly, we use a connection element named GGGGS(BBa K3064025), which connects hsaGlucagon to hsalgG-fc. One of them is the specific binding site of the target receptor--GCGR. The other is the binding part of Trim21(BBa_K2653000).second, it is a kind of self-cleaved sequence named P2A(BBa_K2653003). It allows our part to express two important genes at the same time. Make our parts more efficient. HA(BBa_K2653004), after it, is a marker protein. It allows us to determine whether the protein translated by part is our target protein, which makes our experiment more accurate.
  
 +
Figure 1.Representation of the function of the composite part.
  
 +
<!-- -->
  
 +
===Sequence and Features===
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
<partinfo>BBa_K3064000 SequenceAndFeatures</partinfo>
+
<partinfo>BBa_K3064014 SequenceAndFeatures</partinfo>
  
 +
===Experimental Validation===
  
<!-- Uncomment this to enable Functional Parameter display
+
This composite part is to achieve ubiquitination of GCGR. To verify whether it worked , we did a functional test of it.
===Functional Parameters===
+
First, we used the method of immunoprecipitation to determine whether it was properly translated in the primary hepatocyte system as we wanted. The experimental results were good, which proved the integrity of this functional element.
<partinfo>BBa_K3064000 parameters</partinfo>
+
Then we have an experiment to compared it to a control group. The results shown below illustrate the effectiveness of the part in degrading GCGR, inhibiting glycogenolysis and gluconeogenesis, and decreasing glucose concentration.
<!-- -->
+
  
===Functional Test===
+
https://static.igem.org/mediawiki/parts/c/c0/T--NUDT_CHINA--BBa_K3064014_.jpg
After 18 hours’ transfection, we conduct experiments to test the function of our part. Photograph of fluorescence microscopy helps make results clear and obvious. Meanwhile, with the set of internal control, we can gain relative fluorescence intensity by Image J.  During this process. First, we set different groups with different promoter so that we can understand that the number of CHoRE can influence the promoter's efficiency. And we know that the more CHoRE has, the better effect we have.
+
Then, we set the experiment that 6xGsp-GFP in different glucose concentration for 48 hours'. And we get the result that the effect is different in different glucose concentration.
+
  
https://static.igem.org/mediawiki/parts/c/c1/T--NUDT_CHINA--CHoRE-result.png
 
  
Figure 2: Some structures and results on CHoRE
+
Figure 2. Functional evaluation of the GCGR degradation system in HepG2 cells after 12h of liposome transfection. (A) Co-immunoprecipitation showing binding ability of glucagon-humanIgG Fc fusion protein with glucagon receptor(GCGR). (B) Western Blot showing the result of glucagon receptor(GCGR) degradation.
 +
This part expresses two separate crucial proteins:IgG-Fc fusioned glucagon and HA tagged Trim21. These two parts combines together through binding ability of trim21 N terminal to IgG-Fc. Meanwhile, GCGR binds with glucagon and these three parts form a ternary complex. When trim21 functions as an E3 ubiquitin ligase, the complex would be ubiquitin tagged and degraded through the proteasome pathway. In this way, intracellular GCGR content in hepatocytes would decrease, and so would those distributed in cell membranes. The highlight of this part is that the glucagon in this part can be replaced. It could be an antibody, or it could be another ligand, or else. Almost any protein is possible to be directly degraded in cell if the part expresses some fragments that could binds with the target.
  
Figure 2 (A): Some strutures on CHoRE. Figure 2 (B): minip/3xGsp/6xGsp/9xGsp after 48 hours' transfection in 10 um glucose stimulation. Figure 2 (C): 6xGsp in different glucose concentration after 48 hours.
+
===References===
 +
 
 +
1. Voet D, Voet JG (2011). Biochemistry (4th ed.). New York: Wiley.
 +
 
 +
<!-- Uncomment this to enable Functional Parameter display
 +
===Functional Parameters===
 +
<partinfo>BBa_K3064014 parameters</partinfo>
 +
<!-- -->

Revision as of 06:13, 21 October 2019


hsaGlucagon->GGGGS->hsaIgG-Fc->P2A->HA->hsaTrim21

This is a functional unit of the HepG2, which expresses fusioned hsaGlucagon-GGGGS-hsaIgG-Fc and HA-hsaTrim21 by automatic cleavage of P2A.

Usage and Biology

Our composite part BBa_K3064014 play a necessary effect in our whole RECEPTOR KILLER system. This part is designed to recognised and bind with target protein,and then recruit the proteasome to deplete the target protein through the ubiquitin-proteasome pathway. In this part, hsaGlucagon acts as a bait,which can bind with GCGR, and is linked together with hsalgG-Fc by the designed 4xGS linker to form a recombinate GFP antibody. Trim21, the E3 ubiquitin ligase, plays the most important role in the degradation system. The C-terminal B30.2 domain on trim21 offers a site for the conservative Fc region of human lgG 1,2 and 4 to bind with[1]. When Glucagon is linked to the hsalgG1-Fc, and after the antibody-antigen interaction, a ternary complex is build up. The trim21 then functions as a E3 ubiquitin ligase and proceeds the complex to be depleted through the ubiquitin-proteasome pathway.


Special Design

As a key functional element, special designs are taken for to optimize the applicability and adaptive of such parts . Our part is mainly composed of two important genes, and the efficient expression of these two genes and how to connect them become the focus of our design. Firstly, we use a connection element named GGGGS(BBa K3064025), which connects hsaGlucagon to hsalgG-fc. One of them is the specific binding site of the target receptor--GCGR. The other is the binding part of Trim21(BBa_K2653000).second, it is a kind of self-cleaved sequence named P2A(BBa_K2653003). It allows our part to express two important genes at the same time. Make our parts more efficient. HA(BBa_K2653004), after it, is a marker protein. It allows us to determine whether the protein translated by part is our target protein, which makes our experiment more accurate.

Figure 1.Representation of the function of the composite part.


Sequence and Features

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 1830
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 2499
    Illegal BamHI site found at 3037
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 1787
    Illegal AgeI site found at 632
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 1142
    Illegal BsaI site found at 2877
    Illegal SapI.rc site found at 1490

Experimental Validation

This composite part is to achieve ubiquitination of GCGR. To verify whether it worked , we did a functional test of it. First, we used the method of immunoprecipitation to determine whether it was properly translated in the primary hepatocyte system as we wanted. The experimental results were good, which proved the integrity of this functional element. Then we have an experiment to compared it to a control group. The results shown below illustrate the effectiveness of the part in degrading GCGR, inhibiting glycogenolysis and gluconeogenesis, and decreasing glucose concentration.

T--NUDT_CHINA--BBa_K3064014_.jpg


Figure 2. Functional evaluation of the GCGR degradation system in HepG2 cells after 12h of liposome transfection. (A) Co-immunoprecipitation showing binding ability of glucagon-humanIgG Fc fusion protein with glucagon receptor(GCGR). (B) Western Blot showing the result of glucagon receptor(GCGR) degradation. This part expresses two separate crucial proteins:IgG-Fc fusioned glucagon and HA tagged Trim21. These two parts combines together through binding ability of trim21 N terminal to IgG-Fc. Meanwhile, GCGR binds with glucagon and these three parts form a ternary complex. When trim21 functions as an E3 ubiquitin ligase, the complex would be ubiquitin tagged and degraded through the proteasome pathway. In this way, intracellular GCGR content in hepatocytes would decrease, and so would those distributed in cell membranes. The highlight of this part is that the glucagon in this part can be replaced. It could be an antibody, or it could be another ligand, or else. Almost any protein is possible to be directly degraded in cell if the part expresses some fragments that could binds with the target.

References

1. Voet D, Voet JG (2011). Biochemistry (4th ed.). New York: Wiley.